← Back to all signals
RESEARCH PAPER ANALYSIS

Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study.

AI interpretation is pending for this paper.

Open original publication →
PMID43015836
JournalOrphanet journal of rare diseases
Publication Date2026-08-17
Ingested2026-11-13 10:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is a rare autosomal dominant multisystem disorder caused by NF1 gene variants. Although NF1 shows marked clinical and genetic heterogeneity, large Chinese cohorts integrating clinical features, NF1 variant spectrum, and external variant contextualization remain limited. METHODS: We conducted a cross-sectional study of 847 clinically confirmed Chinese patients with NF1 to characterize demographic features, clinical manifestations, DNB-defined severity, and NF1 variant spectrum. Whole-exome sequencing was performed in 211 patients. Transcript-level variant distribution was assessed using a 500-bp sliding-window approach and further contextualized using ClinVar-derived NF1 variant data. RESULTS: Among 847 patients, the median age was 23 years, 27.5% had a family history of NF1, and more than 90% were younger than 40 years. Café-au-lait macules, neurofibromas, and plexiform neurofibromas were observed in 98.3%, 70.7%, and 20.9% of patients, respectively. Younger age, lower neurofibroma burden, and absence of learning difficulties were associated with DNB-defined mild classification. Among 211 genetically tested patients, pathogenic/likely pathogenic NF1 variants were identified in 182 patients, 11 carried NF1 variants of uncertain significance, and 18 had no reportable NF1 variant. In total, 152 distinct NF1 variants were identified, including 45 novel sites. Transcript-level analysis showed regional variation in reportable nucleotide-level NF1 variants, with relatively higher variant density around exons 10-15 and 44-49. Comparison with ClinVar pathogenic/likely pathogenic NF1 variants showed no significant window-level difference after multiple-testing correction. CONCLUSIONS: This cross-sectional study summarizes the clinical and genetic features of Chinese patients with NF1 and expands the known NF1 variant spectrum in this population. Transcript-level analysis showed regional variation in reportable NF1 variants, broadly paralleling the ClinVar pathogenic/likely pathogenic NF1 variant distribution. These findings provide a basis for future longitudinal studies to validate clinically meaningful genotype-phenotype relationships in NF1.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Potentially Clinically Beneficial Interactions Between Biologically-Based Complementary Medicines and Cancer Treatment: A Systematic Scoping Review. Integrative cancer therapies 87.24 2 RAS inhibition limits oncogenic signaling and tumorigenesis in neuroblastoma regardless of RAS mutational status. Scientific reports 53.7 3 A de novo IKZF4 Variant Underlies Hypogammaglobulinemia and Increased Infection Susceptibility through Downregulating the NF-κB Pathway. Journal of clinical immunology 51.0 4 The impact of chemotherapy on frontal lobe executive functioning in adolescents and young adults diagnosed and treated for blood cancers: a systematic review. BMC cancer 77.14 5 Cutaneous angiomyolipoma presenting as a pilonidal cyst: a case report. Journal of medical case reports 45.5 6 A chemoresistance- and lactylation-related lncRNA prognostic signature uncovers LINC01976/LDHA/lactylation regulatory axis in osteosarcoma chemoresistance. Cellular oncology (Dordrecht, Netherlands) 57.2 7 Model-predicted fludarabine exposure and outcomes after tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia. Cytotherapy 71.7 8 [Testicular leukemia and its treatment in prepubertal males: An update]. Zhonghua nan ke xue = National journal of andrology 68.84 9 Beyond Depression: Suicidality As the First Clue to a Silent Brain Tumor in the Elderly. Cureus 47.5 10 An Atypical Case of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis With Isolated Lower Airway Involvement in a Young Adult. Cureus 58.56 11 Indoor radon monitoring through citizen science in Catalan schools: environmental assessment and educational outcomes. Frontiers in public health 59.5 12 Diet meets biologics: accelerating remission in pediatric Crohn's disease - a real-world experience. Frontiers in gastroenterology (Lausanne, Switzerland) 69.76 13 Dyadic associations between perceived family resilience and fear of disease progression among reproductive-age patients with cervical cancer and their spouses: a cross-sectional study. Frontiers in oncology 64.0 14 Bone marrow CD14+CD206+ M2-like monocyte-macrophages as a potential complementary biomarker for bone marrow MRD in high-risk neuroblastoma. Frontiers in oncology 63.75 15 Comparative analysis of respiratory infection and clinical outcomes in Saudi hematology: malignant versus non-malignant cohorts. Frontiers in cellular and infection microbiology 57.2 16 Assessment of computational methods for fusion transcript detection in targeted RNA-seq samples. Frontiers in bioinformatics 56.0 17 The golden hour: the feasibility of a quality improvement project to decrease the time to antibiotic administration in children with cancer and febrile neutropenia in Jordan. Frontiers in pediatrics 67.9 18 Human models for human diseases: how pluripotent stem cell derived brain organoids can help us understand and treat diffuse hemispheric glioma. Frontiers in cell and developmental biology 50.0 19 Therapeutic enhancement and toxicity reduction of total glucosides of paeony combined with conventional therapy in juvenile idiopathic arthritis: a meta-analysis and network pharmacology. Frontiers in pediatrics 89.7 20 Single-stage combined cardiac and abdominal wall reconstruction in Pentalogy of Cantrell using a cemented sandwich mesh technique: a case report. Frontiers in pediatrics 51.0 21 Metabolic reprogramming in the immune microenvironment of Ewing sarcoma: from mechanisms to therapeutic strategies. Frontiers in immunology 75.5 22 Association of Gut Microbiome Dynamics With Systemic Inflammation and Disease-Free Survival in Osteosarcoma Patients. Cancer medicine 68.62 23 Paediatric Bone Marrow Transplant Outcomes. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 60.7 24 The Hidden Burden: Addressing Disparities in Childhood Cancer Incidence Trends. Cancer reports (Hoboken, N.J.) 38.6 25 Geographic patterns of platform-reported pediatric major-disease cases and healthcare inequality in China: spatial associations and cross-regional healthcare seeking. International journal for equity in health 67.9 26 Carcinoembryonic antigen (CEA) is a useful screening biomarker for inherited glycosylphosphatidylinositol deficiencies. Molecular genetics and metabolism 58.35 27 Acute Hematemesis Leading to the Incidental Diagnosis of Esophageal Squamous Cell Carcinoma in an Adolescent: First Case Report From Pakistan. Clinical case reports 56.3 28 Physiological Uterine Uptake of 18F-MFBG During Menstruation in a Pediatric Patient With Neuroblastoma. Clinical nuclear medicine 68.6 29 ATRT and ETMR: distinct tumors, shared clinical challenges-a comparative narrative review. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 72.1 30 A Comprehensive Radiomics Model for Predicting Progression-Free Survival in High-Risk Neuroblastoma Based on CT Imaging. The British journal of radiology 57.62 31 Response to comment on: "Immune checkpoint therapy in pediatric and adolescent lymphomas". Haematologica 52.36 32 Corrigendum to: IMGP-06. Radiomic Risk Stratification for Pediatric High-Grade Glioma. Neuro-oncology 47.5
PATIENT-FRIENDLY SUMMARY

Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic